Guillain-Barre syndrome associated with idiopathic thrombocytopenic purpura
There is mounting evidence that nerve injury in Guillain-Barre syndrome (GBS) is immunologically mediated, but the roles of cellular and humoral immune mechanisms are uncertain. The association of autoimmune diseases with GBS adds further support to the hypothesis ofan autoimmune basis for this disorder. We report a patient who simultaneously experienced GBS and idiopathic thrombocytopenic purpura (ITP) following an upper respiratory tract infection. This 75 year old woman developed acute progressive quadriparesis two weeks after the start of influenza-like symptoms consisting of fever, sore throat and coryza, which were treated with aspirin and amoxicillin. On examination there was flaccid areflexic quadriplegia (MRC grade 0 to 2), palsies of the right seventh and ninth cranial nerves, and distally diminished sensation in all extremities. Numerous petechiae were observed on the hands, wrists, legs and buccal mucosa. The spleen was not enlarged. Haemoglobin was 13 2 g/dl and haematocrit 38 8%. The white cell count was 12000/mm3, with a normal differential count. Platelet count was 6000/ mm3. The prothrombin time and partial thromboplastin time were normal. Urinalysis was normal except for haematuria. Liver function studies, serum protein electrophoresis, antinuclear antibodies, rheumatoid factor, complement levels and LE test were all negative or normal. An increased number of megakaryocytes was found in an otherwise normal bone marrow examination. Plateletassociated and plasma autoantibodies were investigated by immunofluorescence techniques but failed to demonstrate any immunoreactivity. Prednisone, 60 mg daily, was administered and the platelet count gradually increased to 250000/mm3 on the seventh hospital day.
On During the following days, while there was no fever, the patient became icteric, and developed a hepatosplenomegaly confirmed by echography. There was also a pancytopenia. Peripheral blood films were positive for plasmodium parasites and an indirect immunofluorescent test was positive at 1/2560, suggesting falciparum species. Treatment by mefloquine produced a rapid and complete recovery of the hepatosplenomegaly, pancytopenia and icterus. The cerebellar ataxia improved at the same time. The gait returned to normal two months later. Subsequent blood films for plasmodium were negative.
Even though the so called "cerebellar syndrome" is a well known but uncommon clinical presentation of malaria,' there are few reported cases in the neurological literature. Lemercier et al2 found a transient cerebellar syndrome in two of three patients presenting with severe febrile attacks, but they were usually less prominent than the other general and neurological signs of the attack. Nevertheless, the authors insisted on the frequency of the lesions involving the cerebellum, or its connections on neuropathological examination. Our patient had some common features with the 12 cases from Sri Lanka reported by Senanayake:' cerebellar ataxia, sometimes associated with nystagmus, occurring in a febrile patient during the 15 days following a febrile attack of falciparum malaria. Gametocytes were present in the blood of these patients and the cerebellar signs subsided one to three months after the antimalarial treatment was begun. In the 12 patients the delayed onset of the neurological deficit, the absence of general signs (splenomegaly was present in one patient) and the presence of gametocytes on repeated blood smears (four out of 12 patients) suggested an immuno-allergic mechanism rather than a direct toxic event due to the plasmodium, even though there was a complete neurological recovery.
Our patient had different clinical features from those of the cases reported from Sri Lanka, but were similar to those reported by Girard et 
